Cigna Sues Bristol Myers Squibb Over Pomalyst Monopoly; Louisiana AG Files Three Lawsuits Against CVS Over Text Warnings and Patient Impact

Cigna has filed a lawsuit against Bristol Myers Squibb, accusing the pharmaceutical company of violating U.S. antitrust laws by preventing generic versions of its multiple myeloma drug Pomalyst from entering the market to maintain its monopoly. Meanwhile, Louisiana Attorney General Liz Murrill has initiated three separate lawsuits against CVS, alleging unfair, deceptive, and unlawful practices that have negatively impacted Louisiana patients, independent pharmacies, and the general public. One of the lawsuits highlights CVS's use of text messages warning customers that medication costs might increase and that all CVS pharmacies in Louisiana could close. These legal actions reflect ongoing scrutiny of major pharmaceutical and pharmacy benefit companies regarding their market practices and communications with consumers.